Clinical Trials
3
Active:0
Completed:2
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
- Conditions
- Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2013-09-20
- Lead Sponsor
- Southeastern Gynecologic Oncology
- Target Recruit Count
- 60
- Registration Number
- NCT00897039
- Locations
- 🇺🇸
Southeastern Gynecologic Oncology, LLP - Northside, Atlanta, Georgia, United States
Abraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian Cancer
Phase 2
Completed
- Conditions
- Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
- First Posted Date
- 2007-04-27
- Last Posted Date
- 2011-10-12
- Lead Sponsor
- Southeastern Gynecologic Oncology
- Target Recruit Count
- 40
- Registration Number
- NCT00466986
- Locations
- 🇺🇸
Southeastern Gynecologic Oncology, Atlanta, Georgia, United States
DOXIL for Consolidation Therapy in Ovarian Cancer.
Phase 2
Completed
- Conditions
- Ovarian Neoplasm
- First Posted Date
- 2005-11-03
- Last Posted Date
- 2011-10-12
- Lead Sponsor
- Southeastern Gynecologic Oncology
- Target Recruit Count
- 45
- Registration Number
- NCT00248248
- Locations
- 🇺🇸
Southeastern Gynecologic Oncology, Atlanta, Georgia, United States
News
No news found